|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||355.428 g/mol g·mol−1|
|3D model (JSmol)|
Nalmexone (INN) (code names EN-1620A, UM-592), or nalmexone hydrochloride (USAN), is a semisynthetic, opioid partial agonist or mixed agonist-antagonist with both analgesic and narcotic antagonist properties that was never marketed. In clinical studies it was found to have comparable analgesic efficacy to morphine, though with several-fold reduced potency. In addition, nalmexone's side effects, the most common of which were sleepiness and sweating, were reported to be similar to those of morphine, albeit with a noticeably higher degree of incidence.
|This analgesic-related article is a stub. You can help Wikipedia by expanding it.|